Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients With Relapsed/Refractory Hodgkin Lymphoma

NCT01207921 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01207921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01207921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients With Relapsed/Refractory Hodgkin Lymphoma
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
April 28, 2011
Completion date
March 5, 2021
Enrollment
28 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease